The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
151
247: Vertex vs. insurers, Moderna's future, & b...
STAT’s Ed Silverman joins us to explain how an es…
38 min
152
246: Vas Narasimhan on the future of pharma, pl...
Vas Narasimhan, CEO of Novartis and the new chair…
40 min
153
245: The return of bird flu and the effects of ...
Helen Branswell, STAT’s senior writer covering in…
20 min
154
244: Pharma blockbusters, pandemic policy, & le...
STAT Washington correspondent Rachel Cohrs joins …
35 min
155
243: George Scangos' retirement, annual Covid v...
George Scangos, the CEO of Vir Biotechnology, joi…
31 min
156
242: How blockbusters get made, new vaccines fo...
Journalist Nathan Vardi joins us to talk about hi…
32 min
157
241: #JPM23 in review, the year ahead, & the me...
With the 2023 J.P. Morgan Healthcare Conference d…
32 min
158
240: #JPM23, the future of Alzheimer's, & risin...
First, we delve into a sweeping congressional inv…
36 min
159
239: 2022 in review, CEO indictments, & the yea...
We look back on the biggest biotech stories of 20…
29 min
160
238: Leaky health data, ASH22, & what it takes ...
Katie Palmer, STAT's health tech correspondent, j…
36 min
161
237: The 'electric vehicles' of pharma, Illumin...
STAT's Elaine Chen joins us to explain how the es…
35 min
162
236: Wither PhRMA, Alzheimer's treatment data r...
STAT Washington correspondent Rachel Cohrs joins …
33 min
163
235: LIVE from the STAT Summit
How do Alzheimer’s drugs even work? Can biotech p…
28 min
164
234: Biogen's new CEO, how the midterms affect ...
STAT Washington correspondent Sarah Owermohle joi…
32 min
165
233: How the biotech revolution could come apar...
Our colleague Matthew Herper joins us to discuss …
29 min
166
232: Anti-science at the polls, a biotech odd c...
Our colleague Sarah Owermohle joins us to discuss…
23 min
167
231: BU's Covid tinkering, FDA on trial, & why ...
Lawyer and bioethicist Holly Fernandez Lynch jo…
34 min
168
230: BIO's messy transition, mRNA's future, & B...
STAT Washington correspondent Rachel Cohrs joins …
33 min
169
229: Nobels for science, biotech dealmaking, & ...
The newest Nobel laureates got their phone calls …
28 min
170
228: A surprise success in Alzheimer's and how ...
Lecanemab, a new Alzheimer's treatment from partn…
35 min
171
227: Biden's Covid declaration, twilight of the...
Heidi Tworek, a professor at the University of Br…
34 min
172
226: Pharma's telehealth gold mine, the return ...
Our colleague Katie Palmer joins us to explain a …
27 min
173
225: Illumina's $8 billion limbo, a new treatme...
Our colleague Matthew Herper joins us to discuss …
33 min
174
224: The anti-aging research boom, the Godfathe...
Our colleague Megan Molteni joins us to explain t…
34 min
175
223: Fauci's non-retirement, grading biotech VC...
Our colleague Helen Branswell joins to explain th…
30 min